Skip To Main Content
Sivaraman Ganesan on Muck Rack

Sivaraman Ganesan

As seen in: PLOS, PLOS ONE, Justdial
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sivaraman

Contact Sivaraman, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Correction: Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India

|
By Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, Mahalakshmy Thulasingam
| PLOS ONE
I-MUCOR study group investigators is not included in the author byline. I-MUCOR study group investigators should be listed as the seventy-eighth author.
Open in Who Shared Issue with article?

AI will supplement rather than substitute humans: Sivaraman Ganesan, TCS

|
By Sivaraman Ganesan
| Justdial
Open in Who Shared Issue with article?

Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India

|
By Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, Mahalakshmy Thulasingam
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Abstract Background In the ongoing COVID-19 pandemic, an increased incidence of ROCM was noted in India among those infected with COVID. We determined risk factors for rhino-orbito-cerebral mucormycosis (ROCM) post Coronavirus disease 2019 (COVID-19) among those never and ever hospitalized for COVID-19 separately through a multicentric, hospital-based, unmatched case-control study across India.
Open in Who Shared Issue with article?
See all 4 articles